Drugmaker Doubled Price on Possible Virus Treatment

“The only U.S. drugmaker that makes a potential treatment for the coronavirus that was touted by President Trump raised the price by almost 100 per cent in January, as the virus caused havoc across China,” the Financial Times reports.

“Rising Pharmaceuticals, a New Jersey based company, increased the price of chloroquine — an antimalarial, which is one of the drugs that is being tested against Covid-19 — on January 23, according to data from research firm Elsevier.”